CIK: 0001792126 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $813,433 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 1,300,000 | $88,790 | 10.9% | $51.29 | +15.4% | COM | 03753U106 |
| CYTK | CYTOKINETICS INC | 1,700,000 | $82,365 | 10.1% | $28.97 | +66.1% | COM NEW | 23282W605 |
| IDYA | IDEAYA BIOSCIENCES INC | 4,135,000 | $61,694 | 7.6% | $17.02 | -23.7% | COM | 45166A102 |
| VTYX | VENTYX BIOSCIENCES INC | 1,397,680 | $48,793 | 6.0% | $17.42 | +27.1% | COM | 92332V107 |
| DSGN | DESIGN THERAPEUTICS INC | 2,797,501 | $46,774 | 5.8% | $30.93 | -35.7% | COM | 25056L103 |
| BCYC | BICYCLE THERAPEUTICS PLC | 2,000,000 | $46,520 | 5.7% | $27.16 | — | SPONSORED ADS | 088786108 |
| SRPT | SAREPTA THERAPEUTICS INC | 350,000 | $38,689 | 4.8% | $73.57 | +37.0% | COM | 803607100 |
| — | ALLAKOS INC | 5,936,666 | $36,332 | 4.5% | $6.12 | — | COM | 01671P100 |
| — | KARUNA THERAPEUTICS INC | 150,000 | $33,740 | 4.1% | $115.76 | — | COM | 48576A100 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,525,000 | $29,143 | 3.6% | $19.22 | +17.9% | COM | 03969K108 |
| DYN | DYNE THERAPEUTICS INC | 2,287,321 | $29,049 | 3.6% | $18.68 | -38.6% | COM | 26818M108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 2,971,352 | $28,436 | 3.5% | $37.43 | -68.9% | COM | 00166B105 |
| — | IVERIC BIO INC | 1,500,000 | $26,910 | 3.3% | $17.94 | — | COM | 46583P102 |
| ASND | ASCENDIS PHARMA A/S | 250,000 | $25,815 | 3.2% | $103.26 | — | SPONSORED ADR | 04351P101 |
| — | DICE THERAPEUTICS INC | 1,085,251 | $22,009 | 2.7% | $29.56 | — | COM | 23345J104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,000,000 | $20,510 | 2.5% | $17.98 | 0.0% | COM | 92790C104 |
| XENE | XENON PHARMACEUTICALS INC | 500,000 | $18,050 | 2.2% | $35.95 | 0.0% | COM | 98420N105 |
| IMCR | IMMUNOCORE HLDGS PLC | 350,000 | $16,429 | 2.0% | $46.94 | — | ADS | 45258D105 |
| FULC | FULCRUM THERAPEUTICS INC | 1,950,000 | $15,776 | 1.9% | $14.01 | -48.9% | COM | 359616109 |
| — | AKERO THERAPEUTICS INC | 400,000 | $13,620 | 1.7% | $34.05 | — | COM | 00973Y108 |
| — | NGM BIOPHARMACEUTICALS INC | 850,000 | $11,118 | 1.4% | $13.08 | — | COM | 62921N105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $10,333 | 1.3% | $46.89 | -91.0% | COM | 68062P106 |
| — | TRICIDA INC | 950,000 | $9,956 | 1.2% | $10.48 | — | COM | 89610F101 |
| ALT | ALTIMMUNE INC | 750,000 | $9,578 | 1.2% | $14.76 | 0.0% | COM NEW | 02155H200 |
| — | BELLUS HEALTH INC NEW | 800,000 | $8,448 | 1.0% | $10.56 | — | COM NEW | 07987C204 |
| — | KEZAR LIFE SCIENCES INC | 950,000 | $8,180 | 1.0% | $7.93 | — | COM | 49372L100 |
| CMPS | COMPASS PATHWAYS PLC | 510,000 | $5,472 | 0.7% | $10.73 | — | SPONSORED ADS | 20451W101 |
| GERN | GERON CORP | 2,000,000 | $4,680 | 0.6% | $2.24 | 0.0% | COM | 374163103 |
| IPSC | CENTURY THERAPEUTICS INC | 460,075 | $4,550 | 0.6% | $25.37 | -58.5% | COM | 15673T100 |
| — | TRICIDA INC | 240,200 | $2,517 | 0.3% | $10.48 | — | Put | 89610F101 |
| — | VIGIL NEUROSCIENCE INC | 205,595 | $1,871 | 0.2% | $7.03 | — | COM | 92673K108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 399,801 | $1,607 | 0.2% | $21.54 | — | SPONSORED ADS | 152309100 |
| — | INSTIL BIO INC | 331,872 | $1,606 | 0.2% | $10.75 | — | COM | 45783C101 |
| — | SPRUCE BIOSCIENCES INC | 1,000,000 | $1,370 | 0.2% | $4.46 | — | COM | 85209E109 |
| TYRA | TYRA BIOSCIENCES INC | 127,316 | $1,119 | 0.1% | $19.11 | -52.1% | COM | 90240B106 |
| LIANY | LIANBIO | 307,908 | $616 | 0.1% | $6.16 | — | SPONSORED ADS | 53000N108 |
| — | TALARIS THERAPEUTICS INC | 197,913 | $521 | 0.1% | $14.69 | — | COM | 87410C104 |
| PYXS | PYXIS ONCOLOGY INC | 220,434 | $434 | 0.1% | $11.45 | -77.2% | COMMON STOCK | 747324101 |
| — | NUVATION BIO INC | 66,666 | $13 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |